Tuesday, May 24, 2016

BRIEF-Resverlogix explores potential of Apabetalone in phase 3 Betonmace clinical study

* Potential of Apabetalone for treatment of high-risk

diabetes and CKD is being explored in co's phase 3 Betonmace

clinical study

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)